Courtney Andersen studies the role of estrogen receptor-alpha in ovarian cancer.
Chris Barnes investigates the structural details by which transcription factor activity regulates RNA Polymerase II during the universal process of eukaryotic gene expression.
Soma Jobaggy studies nitrated fatty acid pharmacology and the antioxidant response in hypertensive end-organ damage.
Allison Nagle studies growth factor receptor signaling in breast cancer.
Kara A. Bernstein, PhD
Associate Professor, Microbiology & Molecular Genetics
G.5C Hillman Cancer Center 5117 Centre Avenue
Pittsburgh, PA 15213

Email:
karab@pitt.edu
Phone: 412-864-7742

Fax: 412-623-1010


Education
BA (Biology), Bryn Mawr College, 2000
PhD (Genetics and Development), Yale University, 2006
Postdoctoral Fellow, Columbia University, 2011


Research Areas
DNA Repair
Photo of Kara A. Bernstein, PhD

Repair of DNA damage is crucial to prevent accumulation of mutations that can cause human disease, such as cancer. Our lab studies how double-strand breaks in the DNA, one of the most lethal types of DNA lesions, are repaired. Many proteins are important for DNA repair including Sgs1, a protein that when mutated in human cells leads to many devastating diseases (i.e. Bloom, Werner, Rothmund-Thomson syndromes), which are all fundamentally characterized by cancer predisposition/premature aging. Sgs1 genetically interacts with a group of proteins collectively called the Shu complex. Although Sgs1 has been extensively analyzed, the molecular mechanism of how it functions to repair DNA damage and its relationship to the Shu complex has remained elusive, largely because its deletion leads to many pleiotropic phenotypes. Our lab uses cell biological, molecular, and genetic approaches to study the role of double-strand break repair proteins, such as Sgs1 and the Shu complex, in response to DNA damage. By understanding the mechanism of double-strand break repair and the role of DNA repair proteins in this process, we will uncover mechanisms of tumorigenesis and cancer progression. We will then use this knowledge to aid in diagnosis/prognosis of different types of cancers and to find novel therapeutic targets.

STUDENT NEWS


UPCOMING EVENTS
11/27/2017 8:30 AM Molecular Pharmacology Journal Club
Lloyd Harvey


11/30/2017 12:00 PM Pharmacology & Chemical Biology Seminar Series
Jeffrey L. Brodsky, Ph.D.


12/4/2017 8:30 AM Molecular Pharmacology Journal Club
Andrew Lamade


Pharmacology and Chemical Biology Event Calendar

Program Achievements

Molecular Pharmacology Graduate Program Ranked #2 in National Research Council Rankings

Molecular Pharmacology Graduate Program Ranked #2 in Faculty Scholarly Productivity Index


Outcomes:  Time to disseration, last five graduating clasess:  4.5 years, Completion Rate: 84.8%

Ranked #12 in National of Institute of Health funding of departments of Pharmacology

Ranked in the top 15 in funding for twenty consecutive years




Back to Top